Evidence map›Paper›PMID 36175054›Full record

ArticleJournal of the American College of Cardiology2022

Myocarditis Following SARS-CoV2 mRNA Vaccination Against COVID-19: Facts and Open Questions.

Stephane Heymans, Dana Dawson, Valentin Fuster, Marco Metra, Carlo Gabriele Tocchetti

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the American College of Cardiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Stephane HeymansCardiovascular Research Institute Maastricht, Maastricht University Medical Centre, Maastricht University, Maastricht, the Netherlands; Department of Cardiovascular Sciences, Leuven University, Leuven, Belgium. Electronic address: s.heymans@maastrichtuniversity.nl.
Dana DawsonSchool of Medicine and Dentistry, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, United Kingdom.
Valentin FusterMount Sinai Heart, Mount Sinai Hospital, New York, New York, USA; Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.
Marco MetraInstitute of Cardiology, Civil Hospital, University of Brescia, Brescia, Italy.
Carlo Gabriele TocchettiCardio-Oncology Unit, Department of Translational Medical Sciences, Center for Basic and Clinical Immunology Research, Interdepartmental Center of Clinical and Translational Sciences, Interdepartmental Hypertension Research Center, University of Naples Federico II, Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19MyocarditisHumansRNA, MessengerRNA, ViralSARS-CoV-2VaccinationRNA, MessengerRNA, ViralCOVID-19myocarditisvaccination

Identifiers

PMID36175054
PMCPMC9512040

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.